{"symbol": "MBRX", "companyName": "Moleculin Biotech Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.moleculin.com", "description": "Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The company is engaged in the development of anti-cancer drug candidates. Its drug development technologies include liposomal Annamycin, WP1122 and WP1066.", "CEO": "Walter V. Klemp", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}